Remus Pharmaceuticals Ltd.

•

remuspharma.comBSE: -NSE: REMUS

Market Cap₹ 1,054 Cr.

Current Price

High / Low₹ 988 / 580

Stock P/E28.5

Book Value₹ 298

Price to Book5.15

Dividend Yield0.11 %

ROCE21.9 %

ROE18.6 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company is almost debt free
Working capital cycle has improved - days down from 122 to 59
Company comfortably covers its interest (33.4x coverage)
Institutional investors have been accumulating - FII+DII up 2.2pp
Company converts assets efficiently - asset turnover of 1.6x

CONS

Total debt has risen sharply - up 80.2% year on year
Stock is trading at 5.2x its book value
Rich enterprise valuation - EV/EBITDA of 26.3x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2886.00	52.48	390684.34	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	1002.00	27.32	45485.94	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	AEGISLOG	1286.15	36.08	45143.87	0.68	544.84	210.70	2356.86	37.07	19.76	30.28
4.	CPPLUS	3748.55	92.91	44345.51	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
5.	REDINGTON	372.40	17.12	29113.28	1.61	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	477.45	62.55	15566.03	0.63	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	71.95	97.81	10983.54	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	814.50	82.57	10265.57	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.28	20.88	9342.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1847.60	64.12	8041.32	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	343.50	24.77	7747.24	0.44	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	REMUS	894.10	28.48	1053.61	0.11	—	—	—	—	21.89	—

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

No quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
	213	620
	184	575
Operating Profit	29	46
OPM %	13.60%	7.37%
	3	5
Interest	0	1
Depreciation	1	2
Profit before Tax	30	47
Tax %	19.52%	18.84%
Net Profit	24	38
EPS	139.66	49.35
Dividend Payout %	4.30%	3.04%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: 18%
1 Year:: 1%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: —
Last Year:: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
Equity Capital	1	6
Minority Interest	18	27
	156	250
	14	22
Trade Payables	94	71
	51	57
Total Liabilities	333	433
	14	16
	105	186
	43	52
	115	108
Cash & Bank	14	8
	43	63
Total Assets	333	433

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
	1	7
Cash from Investing	-30	-11
Cash from Financing	28	6
	-1	2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	139.66	49.35
Book Value (₹)	1072.72	434.40
Dividend per Share (₹)	6.00	1.50
Cash EPS (₹)	21.60	34.20
PROFITABILITY
Operating Margin %	13.60%	7.37%
Net Margin %	11.40%	6.19%
ROE %	15.40%	18.58%
ROCE %	18.12%	21.89%
	7.29%	10.03%
EFFICIENCY
Debtor Days	198	66
Inventory Days	74	28
Payable Days	209	57
	62	37
FINANCIAL HEALTH
Debt to Equity (x)	0.07x	0.08x
Interest Coverage (x)	61.34x	33.42x
	1.50x	1.82x
GROWTH
Revenue Growth %	0.00%	191.33%
Operating Profit Growth %	0.00%	59.39%
Net Profit Growth %	0.00%	58.24%
	0.00%	-64.66%
VALUATION
P/E (x)	6.18x	22.68x
P/B (x)	6.43x	5.15x
Dividend Yield %	0.09%	0.07%
	31.83x	26.28x

Shareholding Pattern

Numbers in percentages

	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	69.61	70.60	70.84	70.85	70.91	70.95
	2.38	3.25	3.16	4.77	5.02	5.28
	0.71	0.67	0.77	0.77	0.77	0.83
Government	0.00	0.00	0.00	0.00	0.00	0.00
	27.30	25.49	25.22	23.60	23.31	22.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for REMUS

Loading news…

🤖

AI Stock Analyst

Remus Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2886.00

52.48

390684.34

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

1002.00

27.32

45485.94

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

AEGISLOG

1286.15

36.08

45143.87

0.68

544.84

210.70

2356.86

37.07

19.76

30.28

CPPLUS

3748.55

92.91

44345.51

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

REDINGTON

372.40

17.12

29113.28

1.61

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

477.45

62.55

15566.03

0.63

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

71.95

97.81

10983.54

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

814.50

82.57

10265.57

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.28

20.88

9342.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1847.60

64.12

8041.32

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

343.50

24.77

7747.24

0.44

73.40

-8.99

526.72

-0.43

17.15

18.80

REMUS

894.10

28.48

1053.61

0.11

—

21.89

—

Mar 2024

Mar 2025

213

620

184

575

Operating Profit

OPM %

13.60%

7.37%

Interest

Depreciation

Profit before Tax

Tax %

19.52%

18.84%

Net Profit

EPS

139.66

49.35

Dividend Payout %

4.30%

3.04%

Mar 2024

Mar 2025

Equity Capital

Minority Interest

156

250

Trade Payables

Total Liabilities

333

433

105

186

115

108

Cash & Bank

Total Assets

333

433

Mar 2024

Mar 2025

Cash from Investing

-30

-11

Cash from Financing

-1

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

139.66

49.35

Book Value (₹)

1072.72

434.40

Dividend per Share (₹)

6.00

1.50

Cash EPS (₹)

21.60

34.20

PROFITABILITY

Operating Margin %

13.60%

7.37%

Net Margin %

11.40%

6.19%

ROE %

15.40%

18.58%

ROCE %

18.12%

21.89%

7.29%

10.03%

EFFICIENCY

Debtor Days

198

Inventory Days

Payable Days

209

FINANCIAL HEALTH

Debt to Equity (x)

0.07x

0.08x

Interest Coverage (x)

61.34x

33.42x

1.50x

1.82x

GROWTH

Revenue Growth %

0.00%

191.33%

Operating Profit Growth %

0.00%

59.39%

Net Profit Growth %

0.00%

58.24%

0.00%

-64.66%

VALUATION

P/E (x)

6.18x

22.68x

P/B (x)

6.43x

5.15x

Dividend Yield %

0.09%

0.07%

31.83x

26.28x

Sep 2023

Mar 2024

Sep 2024

Mar 2025

Sep 2025

Mar 2026

69.61

70.60

70.84

70.85

70.91

70.95

2.38

3.25

3.16

4.77

5.02

5.28

0.71

0.67

0.77

0.83

Government

0.00

27.30

25.49

25.22

23.60

23.31

22.94

Remus Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Remus Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI